GREAT POINT PARTNERS LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$308.4B
Holdings
29
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APGEAPOGEE THERAPEUTICS INC | 374,000 | $28.2B | 9.15% | |
| 2 | AMLXAMYLYX PHARMACEUTICALS INC | 1,750,000 | $21.1B | 6.85% | |
| 3 | ZURAZURA BIO LTD | 3,815,930 | $20.0B | 6.48% | |
| 4 | IRONDISC MEDICINE INC | 250,000 | $19.9B | 6.44% | |
| 5 | RAPTRAPT THERAPEUTICS INC | 581,187 | $19.7B | 6.38% | |
| 6 | IMVTIMMUNOVANT INC | 750,000 | $19.1B | 6.18% | |
| 7 | SLNOSOLENO THERAPEUTICS INC | 400,000 | $18.5B | 6.00% | |
| 8 | VORVOR BIOPHARMA INC | 1,370,107 | $17.9B | 5.81% | |
| 9 | DNTHDIANTHUS THERAPEUTICS INC | 350,000 | $14.4B | 4.68% | |
| 10 | JBIOJADE BIOSCIENCES INC | 806,273 | $12.4B | 4.03% | |
| 11 | KALVKALVISTA PHARMACEUTICALS INC | 685,632 | $11.1B | 3.59% | |
| 12 | CTNMCONTINEUM THERAPEUTICS INC | 800,000 | $9.1B | 2.96% | |
| 13 | EPRXEUPRAXIA PHARMACEUTICALS INC | 1,200,000 | $9.1B | 2.94% | |
| 14 | FULCFULCRUM THERAPEUTICS INC | 800,000 | $9.0B | 2.93% | |
| 15 | NKTRNEKTAR THERAPEUTICS | 210,732 | $8.9B | 2.89% | |
| 16 | UPBUPSTREAM BIO INC | 300,000 | $8.1B | 2.64% | |
| 17 | NGNENEUROGENE INC | 350,000 | $7.2B | 2.34% | |
| 18 | RAREULTRAGENYX PHARMACEUTICAL IN | 300,000 | $6.9B | 2.24% | |
| 19 | CNTXCONTEXT THERAPEUTICS INC | 4,683,711 | $6.9B | 2.23% | |
| 20 | CGEMCULLINAN THERAPEUTICS INC | 634,032 | $6.6B | 2.13% | |
| 21 | EVMNEVOMMUNE INC | 325,000 | $5.6B | 1.80% | |
| 22 | ORKAORUKA THERAPEUTICS INC | 183,330 | $5.6B | 1.80% | |
| 23 | SLNSILENCE THERAPEUTICS PLC | 808,032 | $4.9B | 1.59% | |
| 24 | UNCYUNICYCIVE THERAPEUTICS INC | 796,558 | $4.6B | 1.49% | |
| 25 | CLYMCLIMB BIO INC | 979,534 | $3.9B | 1.27% | |
| 26 | SANASANA BIOTECHNOLOGY INC | 700,000 | $2.8B | 0.92% | |
| 27 | PHVSPHARVARIS N V | 82,800 | $2.3B | 0.74% | |
| 28 | AVTXAVALO THERAPEUTICS INC | 124,666 | $2.3B | 0.73% | |
| 29 | RZLTREZOLUTE INC | 951,809 | $2.2B | 0.73% |